Chen C-C CC - OmicsDI

Show results for

Unknown (2979)
Proteomics (94)
Transcriptomics (79)
Genomics (36)
Metabolomics (19)
Genomic (1)
Other (1)
Multiomics (1)

Organisms

Homo sapiens (115)
Mus musculus (38)
Arabidopsis thaliana (10)
Rattus norvegicus (6)
Ovis aries (2)
Danio rerio (2)
Drosophila melanogaster (2)
Pteropus alecto (1)
Manihot esculenta (1)
Tuber melanosporum (1)
Mustela putorius furo (1)
Populus x canadensis (1)
Mus musculus domesticus (1)
Schizosaccharomyces pombe (1)
Bos taurus (1)
Caenorhabditis elegans (1)
Saccharomyces cerevisiae (1)
Aspergillus nidulans (1)
Citrullus lanatus (1)
Coprinopsis cinerea AmutBmut pab1-1 (1)
Haloferax volcanii DS2 (1)
Helicobacter pylori 26695 (1)
Komagataella pastoris (1)
Lentinula edodes (1)
Mycobacterium tuberculosis H37Rv (1)
Myotis pilosus (1)
Oryza sativa (1)
Pleurotus eryngii var. eryngii (1)
Pleurotus ostreatus PC15 (1)

Organisms

Populus x canadensis (1)

Repository

biostudies-arrayexpress (88)
pride (78)
EGA (26)
MetaboLights (17)
MassIVE (13)
GNPS (2)
iProX (2)
dbGaP (1)
GPMDB (1)
PanoramaPublic (1)
ENA (1)

Tissue

Cell culture (19)
Epithelial cell (7)
Blood plasma (5)
Brain (5)
Lung (4)
B cell (2)
Blood (2)
Blood cell (2)
HeLa cell (2)
Kidney (2)
Liver (2)
Testis (2)
Adipose tissue (1)
Blood cancer cell (1)
Blood platelet (1)
Blood serum (1)
Bone cancer cell line (1)
Brain cancer cell line (1)
Breast cancer cell (1)
Breast cancer cell line (1)
Cardiac muscle cell (1)
Cecum cancer cell line (1)
Cerebellar granule cell (1)
Cervical cancer cell line (1)
Colonic cancer cell (1)
Colorectal cancer cell line (1)
Dendritic cell (1)
Egg yolk (1)
Epithelium of pancreatic duct (1)
Fat cell (1)

Disease

Disease free (4)
Breast cancer (3)
Colon cancer (3)
Cardiovascular system disease (2)
Type 2 diabetes mellitus (2)
HPV positive (1)
Leukemia (1)
Not Available (1)
Brain cancer (1)
COVID-19 (1)
Capillary leak syndrome (1)
Cervix carcinoma (1)
Congenital heart disease (1)
Heart disease (1)
Inflammation (1)
Insulin insensitivity (1)
Long COVID (1)
Major depressive disorder (1)
Malignant neoplasm of ovary (1)
Nephrogenic diabetes insipidus (1)
Pancreatic ductal adenocarcinoma (1)
Prostate adenocarcinoma (1)
Secondary progressive multiple sclerosis (1)

Technology Type

Mass Spectrometry (78)
Shotgun proteomics (41)
Bottom-up proteomics (18)
Mass spectrometry (16)
Data-dependent acquisition (8)
Gel-based experiment (8)
Affinity purification coupled with mass spectrometry proteomics (4)
Data-independent acquisition (3)
AB 5500 Genetic Analyzer, Ion Torrent PGM (1)
Illumina HiSeq 1000, Ion Torrent PGM, Illumina Genome Analyzer IIx (1)
Illumina HiSeq 2500 (1)
Life Tech - Solid (1)
Mass spectrometry assay (1)
Affinity proteomics (1)
All-ion fragmentation (1)
Proteogenomics (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Liquid Chromatography MS - positive - reverse phase (8)
LTQ Orbitrap Elite (4)
TripleTOF 5600 (3)
Illumina HiSeq 4000 (2)
LTQ Velos (2)
Gas Chromatography MS - (2)
Liquid Chromatography MS - negative - reverse phase (2)
Dell T8310 (1)
Axon GenePix 4000B scanning hardware (1)
Illumina HiSeq X (1)
Illumina HiSeq 2500 (1)
LTQ FT (1)
MaXis (1)
Q Exactive Plus (1)
Instrument (1)
LTQ Orbitrap (1)
LTQ Orbitrap Velos (1)
Orbitrap Exploris 480 (1)
Orbitrap Fusion ETD (1)
Q Exactive (1)
Q-Exactive HF (1)
TripleTOF 6600 (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - Negative (LC-MS (Negative)) (1)
Liquid Chromatography MS - Positive (LC-MS (Positive)) (1)
Liquid Chromatography MS - negative (1)
Liquid Chromatography MS - positive (1)
MS Imaging - (1)
MaXis (Bruker) (1)
TripleTOF 5600 (AB Sciex) (1)

Publication Date

2023 (18)
2014 (16)
2022 (16)
2012 (15)
2015 (14)
2018 (14)
2024 (13)
2013 (12)
2010 (11)
2025 (11)
2021 (10)
2019 (9)
2026 (9)
2016 (7)
2020 (6)
2017 (6)
2011 (5)
2009 (3)
2008 (2)
2006 (2)
2007 (1)
2003 (1)

CHEBI ID

CHEBI:28865 (5)
CHEBI:16359 (4)
CHEBI:16811 (3)
CHEBI:17148 (3)
CHEBI:27432 (3)
CHEBI:30769 (3)
CHEBI:35038 (3)
CHEBI:64489 (3)
CHEBI:64563 (3)
CHEBI:73858 (3)
CHEBI:80774 (3)
CHEBI:10136 (2)
CHEBI:116314 (2)
CHEBI:131342 (2)
CHEBI:139138 (2)
CHEBI:143745 (2)
CHEBI:143757 (2)
CHEBI:15366 (2)
CHEBI:15428 (2)
CHEBI:15741 (2)
CHEBI:15756 (2)
CHEBI:15843 (2)
CHEBI:16196 (2)
CHEBI:16411 (2)
CHEBI:16414 (2)
CHEBI:16467 (2)
CHEBI:16551 (2)
CHEBI:16610 (2)
CHEBI:16750 (2)
CHEBI:16755 (2)

Metabolite Name

1-Stearoyl-2-hydroxy-sn-glycero-3-phosphocholine (3)
Cholic acid (3)
Citric acid (3)
Tris(2-butoxyethyl) phosphate (3)
(2S,3S,4S,5R,6R)-6-[[(3S,4S,6aR,6bS,8aR,9R,12aS,14bR)-9-hydroxy-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-5-[(2S,3R,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxyoxane-2-carboxylic acid (2)
1-(9Z-Octadecenoyl)-sn-glycero-3-phosphocholine (2)
1-({[2-(2-furylmethyl)-5-methylpyrrolidinyl]amino}methylene)-7-[8-({[2-(2-fury lmethyl)pyrrolidinyl]amino}methylene)-1,6-dihydroxy-3-methyl-5-(methylethyl)-7 -oxo(2-naphthyl)]-3,8-dihydroxy-6-methyl-4-(methylethyl)naphthalen-2-one (2)
2,6-Di-tert-butyl-4-hydroxymethylphenol (2)
9(10)-EpOME (2)
Acetic acid (2)
Conjugated linoleic Acid (10E,12Z) (2)
Dodecanoic acid (2)
Elaidic acid (2)
Fumaric acid (2)
Glycine (2)
L-Tyrosine (2)
Lyso-PC(16:0) (2)
Methionine (2)
Monoelaidin (2)
Monoolein (2)
Myristoleic acid (2)
NCGC00385123-01_C22H30O6_7b,9-Dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1,1a,1b,4,4a,5,7a,7b,8,9-decahydro-9aH-cyclopropa[3,4]benzo[1,2-e]azulen-9a-yl acetate (2)
Ornithine (2)
Oxalic acid (2)
Palmitic acid (2)
Purine (2)
Putrescine (2)
Spermidine (2)
Stearic acid (2)
Succinic acid (2)

First Public Date

2014 (1)

Study type

Transcription profiling by array (51)
RNA-seq of coding RNA (15)
Unknown experiment type (6)
ChIP-seq (4)
Methylation profiling by high throughput sequencing (4)
Methylation profiling by array (3)
Human - Single-cell sequencing (1)
Comparative genomic hybridization by array (1)
Other (1)
DNA-seq (1)
RNA-seq of non coding RNA (1)

Release Date

2022 (300)
2021 (276)
2023 (261)
2024 (249)
2020 (237)
2025 (223)
2018 (208)
2017 (196)
2019 (189)
2015 (186)
2016 (167)
2014 (155)
2013 (98)
2012 (90)
2011 (72)
2010 (56)
2026 (29)
2009 (26)
2008 (16)
2005 (9)
2007 (8)
2006 (8)
2002 (3)
2003 (2)
2004 (1)
2001 (1)
1999 (1)

Lab affiliation

Institute of Chemistry, Academia Sinica (3)
Institute of Clinical Medicine in National Yang-Ming Chiao Tung University, Taiwan (Muh-Hwa Yang Lab) (3)
Metabolomics-Proteomics Research Center, National Yang Ming Chiao Tung University, Taipei 11221, Taiwan (3)
Charles Perkins Centre, School of Life and Environmental Sciences and Sydney Medical School, University of Sydney, Camperdown, NSW, Australia (2)
Icahn School of Medicine at Mount Sinai (2)
Institute of Plant and Microbial Biology, Academia Sinica (2)
1 Department of Genetics, Harvard Medical School, Boston, MA 02115 (1)
1Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO 80045, USA (1)
2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Tianjin Key Laboratory of Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China (1)
Beijing Academy of Agriculture and Forestry Sciences (1)
Chang Gung Memorial Hospital (1)
Chun-Hung Lin's Lab, Institute of Biological Chemistry, Academia Sinica, No. 128 Academic Road Section 2, Nan-Kang, Taipei, 11529, Taiwan (1)
Clinical Proteomics Lab, Chang Gung Memorial Hospital, Linkou, Taiwan. (1)
Department of Andrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510080, China (1)
Department of Biochemistry, Purdue University, West Lafayette, IN USA (1)
Department of Biomedical Science and Environmental Biology, College of Life Science, Kaohsiung Medical University (1)
Department of Cancer Biology, Wake Forest Baptist Hospital (1)
Department of Cardiology, The Second Affiliated Hospital of Fujian Medical University, 950 Donghai Street, Fengze District, Quanzhou, Fujian Province, 362000, China. (1)
Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA (1)
Department of Developmental and Molecular Biology, Albert Einstein College of Medicine, Bronx, NY 10461, USA. (1)
Department of Genetics, Harvard Medical School, Boston, MA 02115 (1)
Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taiwan, Republic of China (1)
Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Taoyuan, Taiwan (1)
Department of Medical Biotechnology and Laboratory Science, College of Medicine, Chang Gung University, Taiwan (1)
Department of Medical Laboratory Science and Biotechnology, College of Medicine, National Cheng Kung University, Tainan, Taiwan. (1)
Department of Microbiology and Immunology, China Medical University, Taichung 404328, Taiwan (1)
Department of Molecular Medicine, The Scripps Research Institute (1)
Department of Molecular Physiology, Leiden Institute of Chemistry, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands (1)
Department of Neurology, Xiangya Hospital, Central South University (1)
Department of Obstetrics and Gynecology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai Jiao Tong University School of medicine (1)

Tags

xref:PubMed:18721163 (1)

Previous page
1 / 321
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 321
Next page

Sort by:

Relevance

Page size

Metabolomics to elucidate the effects of novel sustainable feed additives in the feed of farmed salmon (HoloFood Trial C - blue mussel ensilage-dose response)

Testing the effect of blue mussel ensilage as a novel cost-efficient protein feed source for Atlantic salmon feed. Fermentation of novel raw materials for fish feed is a new practice with little prior experience of direct relevance to aquaculture and fish farming. In Trial C, alternative processi...

2023-06-13 | MTBLS4384 | MetaboLights

Safety, Pharmacokinetics, and Pharmacodynamics of CC-90001 (BMS-986360), a c-Jun N-terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.

Not available

S-EPMC10092235 | biostudies-literature

Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population.

Not available

S-EPMC4194587 | biostudies-literature

Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection.

Not available

S-EPMC4998890 | biostudies-literature

Comparison of Elixhauser and Charlson Methods for Predicting Oral Cancer Survival.

Not available

S-EPMC4998653 | biostudies-literature

Bisulfite-Seq profiling of wild-type Arabidopsis with two-component transgene silencing (T+S) system

In plants, RNA polymerase II (Pol II) transcription of inverted DNA repeats produces hairpin RNAs that are processed by several DICER-LIKE enzymes into siRNAs that are 21-24-nt in length. When targeted to transcriptional regulatory regions, the 24-nt size class can induce RNA-directed DNA methylatio...

ORGANISM(S): Arabidopsis thaliana

2013-05-30 | E-GEOD-47453 | biostudies-arrayexpress

Association between hsa-miR-34b/c rs4938723 T > C promoter polymorphism and cancer risk: a meta-analysis based on 6,036 cases and 6,204 controls.

Not available

S-EPMC4076713 | biostudies-literature

Gene expression profiling of oral squamous cell carcinoma (OSCC)

According to epidemiological studies, a vast majority, approximately 80%~90% of male OSCC patients in Taiwan habitually drink alcohol (A), and chew betel quid (B), and use cigarette (C). To assess the impact of these dietary factors on the transcriptom, we conduct a high-throughput screen survey in ...

ORGANISM(S): Homo sapiens

2013-05-02 | E-GEOD-37991 | biostudies-arrayexpress

Clinical Study on the Relationship between the SNP rs8192675 (C/C) Site of SLC2A2 Gene and the Hypoglycemic Effect of Metformin in Type 2 Diabetes.

Not available

S-EPMC8820847 | biostudies-literature

Hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A polymorphisms are associated with the risk of esophageal cancer in a Chinese population.

Not available

S-EPMC3832359 | biostudies-literature